nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenac—CYP3A4—bone cancer	0.179	0.505	CbGaD
Diclofenac—PTGS2—bone cancer	0.175	0.495	CbGaD
Diclofenac—UGT2B7—Epirubicin—bone cancer	0.0673	0.157	CbGbCtD
Diclofenac—SLCO1C1—Methotrexate—bone cancer	0.0638	0.149	CbGbCtD
Diclofenac—ABCC1—Epirubicin—bone cancer	0.0478	0.112	CbGbCtD
Diclofenac—SLC22A11—Methotrexate—bone cancer	0.0329	0.0769	CbGbCtD
Diclofenac—ABCC4—Methotrexate—bone cancer	0.0306	0.0715	CbGbCtD
Diclofenac—PTGS2—Cisplatin—bone cancer	0.0277	0.0648	CbGbCtD
Diclofenac—ABCC1—Doxorubicin—bone cancer	0.0254	0.0594	CbGbCtD
Diclofenac—ABCC1—Methotrexate—bone cancer	0.0246	0.0575	CbGbCtD
Diclofenac—SLC22A8—Methotrexate—bone cancer	0.0191	0.0447	CbGbCtD
Diclofenac—CYP2B6—Cisplatin—bone cancer	0.0178	0.0417	CbGbCtD
Diclofenac—SLC22A6—Methotrexate—bone cancer	0.0133	0.0311	CbGbCtD
Diclofenac—CYP2B6—Doxorubicin—bone cancer	0.012	0.0279	CbGbCtD
Diclofenac—ALB—Methotrexate—bone cancer	0.0114	0.0265	CbGbCtD
Diclofenac—CYP2C9—Cisplatin—bone cancer	0.00943	0.022	CbGbCtD
Diclofenac—ABCB1—Cisplatin—bone cancer	0.00915	0.0214	CbGbCtD
Diclofenac—ABCB1—Doxorubicin—bone cancer	0.00613	0.0143	CbGbCtD
Diclofenac—ABCB1—Methotrexate—bone cancer	0.00594	0.0139	CbGbCtD
Diclofenac—CYP3A4—Doxorubicin—bone cancer	0.00367	0.00858	CbGbCtD
Diclofenac—Guanfacine—CYP3A4—bone cancer	0.000717	0.195	CrCbGaD
Diclofenac—Bromfenac—PTGS2—bone cancer	0.000673	0.183	CrCbGaD
Diclofenac—Lumiracoxib—PTGS2—bone cancer	0.000573	0.156	CrCbGaD
Diclofenac—Nepafenac—PTGS2—bone cancer	0.000545	0.148	CrCbGaD
Diclofenac—Meclofenamic acid—PTGS2—bone cancer	0.000446	0.121	CrCbGaD
Diclofenac—Clonidine—CYP3A4—bone cancer	0.000377	0.102	CrCbGaD
Diclofenac—Mefenamic acid—PTGS2—bone cancer	0.000347	0.0943	CrCbGaD
Diclofenac—TTR—vertebral column—bone cancer	0.000305	0.161	CbGeAlD
Diclofenac—CXCR1—bone marrow—bone cancer	0.000158	0.0836	CbGeAlD
Diclofenac—PTGS2—periosteum—bone cancer	0.000128	0.0677	CbGeAlD
Diclofenac—PTGS2—leg—bone cancer	0.000102	0.054	CbGeAlD
Diclofenac—Rhinitis—Epirubicin—bone cancer	0.000101	0.000785	CcSEcCtD
Diclofenac—Urinary tract infection—Doxorubicin—bone cancer	0.000101	0.000785	CcSEcCtD
Diclofenac—Conjunctivitis—Doxorubicin—bone cancer	0.000101	0.000785	CcSEcCtD
Diclofenac—Hepatitis—Epirubicin—bone cancer	0.000101	0.000783	CcSEcCtD
Diclofenac—Haemorrhage—Epirubicin—bone cancer	0.000101	0.000783	CcSEcCtD
Diclofenac—Eye disorder—Methotrexate—bone cancer	0.000101	0.000782	CcSEcCtD
Diclofenac—Tinnitus—Methotrexate—bone cancer	0.000101	0.00078	CcSEcCtD
Diclofenac—Hypoaesthesia—Epirubicin—bone cancer	0.000101	0.000779	CcSEcCtD
Diclofenac—Asthenia—Cisplatin—bone cancer	0.0001	0.000777	CcSEcCtD
Diclofenac—Pharyngitis—Epirubicin—bone cancer	0.0001	0.000777	CcSEcCtD
Diclofenac—Cardiac disorder—Methotrexate—bone cancer	0.0001	0.000777	CcSEcCtD
Diclofenac—Sweating—Doxorubicin—bone cancer	9.98e-05	0.000774	CcSEcCtD
Diclofenac—Urinary tract disorder—Epirubicin—bone cancer	9.98e-05	0.000773	CcSEcCtD
Diclofenac—Oedema peripheral—Epirubicin—bone cancer	9.95e-05	0.000771	CcSEcCtD
Diclofenac—Haematuria—Doxorubicin—bone cancer	9.93e-05	0.00077	CcSEcCtD
Diclofenac—Urethral disorder—Epirubicin—bone cancer	9.9e-05	0.000768	CcSEcCtD
Diclofenac—Hepatobiliary disease—Doxorubicin—bone cancer	9.85e-05	0.000763	CcSEcCtD
Diclofenac—Epistaxis—Doxorubicin—bone cancer	9.82e-05	0.000761	CcSEcCtD
Diclofenac—Angiopathy—Methotrexate—bone cancer	9.79e-05	0.000759	CcSEcCtD
Diclofenac—Sinusitis—Doxorubicin—bone cancer	9.77e-05	0.000757	CcSEcCtD
Diclofenac—Immune system disorder—Methotrexate—bone cancer	9.75e-05	0.000756	CcSEcCtD
Diclofenac—Visual impairment—Epirubicin—bone cancer	9.74e-05	0.000755	CcSEcCtD
Diclofenac—Mediastinal disorder—Methotrexate—bone cancer	9.73e-05	0.000754	CcSEcCtD
Diclofenac—Agranulocytosis—Doxorubicin—bone cancer	9.72e-05	0.000753	CcSEcCtD
Diclofenac—Chills—Methotrexate—bone cancer	9.69e-05	0.000751	CcSEcCtD
Diclofenac—Diarrhoea—Cisplatin—bone cancer	9.56e-05	0.000741	CcSEcCtD
Diclofenac—Erythema multiforme—Epirubicin—bone cancer	9.55e-05	0.00074	CcSEcCtD
Diclofenac—Alopecia—Methotrexate—bone cancer	9.54e-05	0.000739	CcSEcCtD
Diclofenac—Bradycardia—Doxorubicin—bone cancer	9.52e-05	0.000738	CcSEcCtD
Diclofenac—Mental disorder—Methotrexate—bone cancer	9.46e-05	0.000733	CcSEcCtD
Diclofenac—Eye disorder—Epirubicin—bone cancer	9.44e-05	0.000732	CcSEcCtD
Diclofenac—Tinnitus—Epirubicin—bone cancer	9.42e-05	0.00073	CcSEcCtD
Diclofenac—Malnutrition—Methotrexate—bone cancer	9.4e-05	0.000728	CcSEcCtD
Diclofenac—Erythema—Methotrexate—bone cancer	9.4e-05	0.000728	CcSEcCtD
Diclofenac—Haemoglobin—Doxorubicin—bone cancer	9.4e-05	0.000728	CcSEcCtD
Diclofenac—Cardiac disorder—Epirubicin—bone cancer	9.38e-05	0.000727	CcSEcCtD
Diclofenac—Flushing—Epirubicin—bone cancer	9.38e-05	0.000727	CcSEcCtD
Diclofenac—Rhinitis—Doxorubicin—bone cancer	9.37e-05	0.000726	CcSEcCtD
Diclofenac—Haemorrhage—Doxorubicin—bone cancer	9.35e-05	0.000725	CcSEcCtD
Diclofenac—Hepatitis—Doxorubicin—bone cancer	9.35e-05	0.000725	CcSEcCtD
Diclofenac—ASIC1—spinal cord—bone cancer	9.34e-05	0.0495	CbGeAlD
Diclofenac—Hypoaesthesia—Doxorubicin—bone cancer	9.3e-05	0.000721	CcSEcCtD
Diclofenac—Pharyngitis—Doxorubicin—bone cancer	9.28e-05	0.000719	CcSEcCtD
Diclofenac—Urinary tract disorder—Doxorubicin—bone cancer	9.23e-05	0.000716	CcSEcCtD
Diclofenac—Oedema peripheral—Doxorubicin—bone cancer	9.21e-05	0.000714	CcSEcCtD
Diclofenac—Dysgeusia—Methotrexate—bone cancer	9.2e-05	0.000713	CcSEcCtD
Diclofenac—Angiopathy—Epirubicin—bone cancer	9.17e-05	0.00071	CcSEcCtD
Diclofenac—Urethral disorder—Doxorubicin—bone cancer	9.16e-05	0.00071	CcSEcCtD
Diclofenac—Immune system disorder—Epirubicin—bone cancer	9.13e-05	0.000707	CcSEcCtD
Diclofenac—Mediastinal disorder—Epirubicin—bone cancer	9.11e-05	0.000706	CcSEcCtD
Diclofenac—PTGS2—hindlimb—bone cancer	9.11e-05	0.0482	CbGeAlD
Diclofenac—Back pain—Methotrexate—bone cancer	9.09e-05	0.000705	CcSEcCtD
Diclofenac—Chills—Epirubicin—bone cancer	9.06e-05	0.000703	CcSEcCtD
Diclofenac—Arrhythmia—Epirubicin—bone cancer	9.03e-05	0.0007	CcSEcCtD
Diclofenac—Visual impairment—Doxorubicin—bone cancer	9.01e-05	0.000698	CcSEcCtD
Diclofenac—PTGS2—cartilage tissue—bone cancer	8.96e-05	0.0475	CbGeAlD
Diclofenac—Alopecia—Epirubicin—bone cancer	8.93e-05	0.000692	CcSEcCtD
Diclofenac—Vomiting—Cisplatin—bone cancer	8.89e-05	0.000689	CcSEcCtD
Diclofenac—Vision blurred—Methotrexate—bone cancer	8.86e-05	0.000687	CcSEcCtD
Diclofenac—Mental disorder—Epirubicin—bone cancer	8.85e-05	0.000686	CcSEcCtD
Diclofenac—Erythema multiforme—Doxorubicin—bone cancer	8.84e-05	0.000685	CcSEcCtD
Diclofenac—Rash—Cisplatin—bone cancer	8.81e-05	0.000683	CcSEcCtD
Diclofenac—Dermatitis—Cisplatin—bone cancer	8.8e-05	0.000682	CcSEcCtD
Diclofenac—Malnutrition—Epirubicin—bone cancer	8.79e-05	0.000682	CcSEcCtD
Diclofenac—Erythema—Epirubicin—bone cancer	8.79e-05	0.000682	CcSEcCtD
Diclofenac—Eye disorder—Doxorubicin—bone cancer	8.74e-05	0.000677	CcSEcCtD
Diclofenac—Ill-defined disorder—Methotrexate—bone cancer	8.72e-05	0.000676	CcSEcCtD
Diclofenac—Tinnitus—Doxorubicin—bone cancer	8.72e-05	0.000676	CcSEcCtD
Diclofenac—Anaemia—Methotrexate—bone cancer	8.69e-05	0.000673	CcSEcCtD
Diclofenac—Cardiac disorder—Doxorubicin—bone cancer	8.68e-05	0.000672	CcSEcCtD
Diclofenac—Flushing—Doxorubicin—bone cancer	8.68e-05	0.000672	CcSEcCtD
Diclofenac—Flatulence—Epirubicin—bone cancer	8.67e-05	0.000672	CcSEcCtD
Diclofenac—Tension—Epirubicin—bone cancer	8.63e-05	0.000669	CcSEcCtD
Diclofenac—Dysgeusia—Epirubicin—bone cancer	8.61e-05	0.000668	CcSEcCtD
Diclofenac—Nervousness—Epirubicin—bone cancer	8.54e-05	0.000662	CcSEcCtD
Diclofenac—Back pain—Epirubicin—bone cancer	8.51e-05	0.000659	CcSEcCtD
Diclofenac—PLA2G2A—connective tissue—bone cancer	8.49e-05	0.045	CbGeAlD
Diclofenac—Angiopathy—Doxorubicin—bone cancer	8.48e-05	0.000657	CcSEcCtD
Diclofenac—Malaise—Methotrexate—bone cancer	8.47e-05	0.000657	CcSEcCtD
Diclofenac—Muscle spasms—Epirubicin—bone cancer	8.46e-05	0.000655	CcSEcCtD
Diclofenac—Immune system disorder—Doxorubicin—bone cancer	8.44e-05	0.000654	CcSEcCtD
Diclofenac—Vertigo—Methotrexate—bone cancer	8.44e-05	0.000654	CcSEcCtD
Diclofenac—Mediastinal disorder—Doxorubicin—bone cancer	8.42e-05	0.000653	CcSEcCtD
Diclofenac—Leukopenia—Methotrexate—bone cancer	8.41e-05	0.000652	CcSEcCtD
Diclofenac—Chills—Doxorubicin—bone cancer	8.39e-05	0.00065	CcSEcCtD
Diclofenac—Arrhythmia—Doxorubicin—bone cancer	8.35e-05	0.000647	CcSEcCtD
Diclofenac—Nausea—Cisplatin—bone cancer	8.3e-05	0.000644	CcSEcCtD
Diclofenac—Vision blurred—Epirubicin—bone cancer	8.29e-05	0.000642	CcSEcCtD
Diclofenac—Alopecia—Doxorubicin—bone cancer	8.26e-05	0.00064	CcSEcCtD
Diclofenac—Cough—Methotrexate—bone cancer	8.2e-05	0.000636	CcSEcCtD
Diclofenac—Mental disorder—Doxorubicin—bone cancer	8.19e-05	0.000635	CcSEcCtD
Diclofenac—Ill-defined disorder—Epirubicin—bone cancer	8.16e-05	0.000633	CcSEcCtD
Diclofenac—Convulsion—Methotrexate—bone cancer	8.14e-05	0.000631	CcSEcCtD
Diclofenac—Malnutrition—Doxorubicin—bone cancer	8.14e-05	0.000631	CcSEcCtD
Diclofenac—Erythema—Doxorubicin—bone cancer	8.14e-05	0.000631	CcSEcCtD
Diclofenac—Anaemia—Epirubicin—bone cancer	8.13e-05	0.00063	CcSEcCtD
Diclofenac—Agitation—Epirubicin—bone cancer	8.08e-05	0.000626	CcSEcCtD
Diclofenac—Flatulence—Doxorubicin—bone cancer	8.02e-05	0.000622	CcSEcCtD
Diclofenac—Myalgia—Methotrexate—bone cancer	8e-05	0.00062	CcSEcCtD
Diclofenac—Arthralgia—Methotrexate—bone cancer	8e-05	0.00062	CcSEcCtD
Diclofenac—Chest pain—Methotrexate—bone cancer	8e-05	0.00062	CcSEcCtD
Diclofenac—Tension—Doxorubicin—bone cancer	7.99e-05	0.000619	CcSEcCtD
Diclofenac—Dysgeusia—Doxorubicin—bone cancer	7.97e-05	0.000618	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	7.95e-05	0.000616	CcSEcCtD
Diclofenac—Malaise—Epirubicin—bone cancer	7.93e-05	0.000615	CcSEcCtD
Diclofenac—Discomfort—Methotrexate—bone cancer	7.9e-05	0.000613	CcSEcCtD
Diclofenac—Nervousness—Doxorubicin—bone cancer	7.9e-05	0.000613	CcSEcCtD
Diclofenac—Vertigo—Epirubicin—bone cancer	7.9e-05	0.000612	CcSEcCtD
Diclofenac—Syncope—Epirubicin—bone cancer	7.89e-05	0.000611	CcSEcCtD
Diclofenac—Leukopenia—Epirubicin—bone cancer	7.87e-05	0.00061	CcSEcCtD
Diclofenac—Back pain—Doxorubicin—bone cancer	7.87e-05	0.00061	CcSEcCtD
Diclofenac—Muscle spasms—Doxorubicin—bone cancer	7.82e-05	0.000606	CcSEcCtD
Diclofenac—PTGS2—appendage—bone cancer	7.81e-05	0.0414	CbGeAlD
Diclofenac—Palpitations—Epirubicin—bone cancer	7.77e-05	0.000602	CcSEcCtD
Diclofenac—Confusional state—Methotrexate—bone cancer	7.73e-05	0.000599	CcSEcCtD
Diclofenac—Loss of consciousness—Epirubicin—bone cancer	7.73e-05	0.000599	CcSEcCtD
Diclofenac—Cough—Epirubicin—bone cancer	7.67e-05	0.000595	CcSEcCtD
Diclofenac—Anaphylactic shock—Methotrexate—bone cancer	7.67e-05	0.000595	CcSEcCtD
Diclofenac—Vision blurred—Doxorubicin—bone cancer	7.67e-05	0.000594	CcSEcCtD
Diclofenac—Convulsion—Epirubicin—bone cancer	7.62e-05	0.000591	CcSEcCtD
Diclofenac—Infection—Methotrexate—bone cancer	7.62e-05	0.000591	CcSEcCtD
Diclofenac—Hypertension—Epirubicin—bone cancer	7.59e-05	0.000589	CcSEcCtD
Diclofenac—Ill-defined disorder—Doxorubicin—bone cancer	7.55e-05	0.000585	CcSEcCtD
Diclofenac—Nervous system disorder—Methotrexate—bone cancer	7.52e-05	0.000583	CcSEcCtD
Diclofenac—Anaemia—Doxorubicin—bone cancer	7.52e-05	0.000583	CcSEcCtD
Diclofenac—Thrombocytopenia—Methotrexate—bone cancer	7.51e-05	0.000582	CcSEcCtD
Diclofenac—Arthralgia—Epirubicin—bone cancer	7.49e-05	0.00058	CcSEcCtD
Diclofenac—Myalgia—Epirubicin—bone cancer	7.49e-05	0.00058	CcSEcCtD
Diclofenac—Chest pain—Epirubicin—bone cancer	7.49e-05	0.00058	CcSEcCtD
Diclofenac—Agitation—Doxorubicin—bone cancer	7.48e-05	0.00058	CcSEcCtD
Diclofenac—Anxiety—Epirubicin—bone cancer	7.46e-05	0.000578	CcSEcCtD
Diclofenac—Skin disorder—Methotrexate—bone cancer	7.45e-05	0.000577	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	7.44e-05	0.000576	CcSEcCtD
Diclofenac—Hyperhidrosis—Methotrexate—bone cancer	7.41e-05	0.000575	CcSEcCtD
Diclofenac—Discomfort—Epirubicin—bone cancer	7.4e-05	0.000573	CcSEcCtD
Diclofenac—Malaise—Doxorubicin—bone cancer	7.34e-05	0.000569	CcSEcCtD
Diclofenac—Dry mouth—Epirubicin—bone cancer	7.32e-05	0.000568	CcSEcCtD
Diclofenac—Vertigo—Doxorubicin—bone cancer	7.31e-05	0.000567	CcSEcCtD
Diclofenac—Anorexia—Methotrexate—bone cancer	7.31e-05	0.000567	CcSEcCtD
Diclofenac—Syncope—Doxorubicin—bone cancer	7.3e-05	0.000566	CcSEcCtD
Diclofenac—Leukopenia—Doxorubicin—bone cancer	7.28e-05	0.000565	CcSEcCtD
Diclofenac—Confusional state—Epirubicin—bone cancer	7.24e-05	0.000561	CcSEcCtD
Diclofenac—Palpitations—Doxorubicin—bone cancer	7.19e-05	0.000557	CcSEcCtD
Diclofenac—Oedema—Epirubicin—bone cancer	7.18e-05	0.000556	CcSEcCtD
Diclofenac—Anaphylactic shock—Epirubicin—bone cancer	7.18e-05	0.000556	CcSEcCtD
Diclofenac—Hypotension—Methotrexate—bone cancer	7.17e-05	0.000556	CcSEcCtD
Diclofenac—Loss of consciousness—Doxorubicin—bone cancer	7.15e-05	0.000554	CcSEcCtD
Diclofenac—Infection—Epirubicin—bone cancer	7.13e-05	0.000553	CcSEcCtD
Diclofenac—Cough—Doxorubicin—bone cancer	7.1e-05	0.00055	CcSEcCtD
Diclofenac—Shock—Epirubicin—bone cancer	7.06e-05	0.000547	CcSEcCtD
Diclofenac—Convulsion—Doxorubicin—bone cancer	7.05e-05	0.000547	CcSEcCtD
Diclofenac—Nervous system disorder—Epirubicin—bone cancer	7.04e-05	0.000546	CcSEcCtD
Diclofenac—Thrombocytopenia—Epirubicin—bone cancer	7.03e-05	0.000545	CcSEcCtD
Diclofenac—Hypertension—Doxorubicin—bone cancer	7.03e-05	0.000545	CcSEcCtD
Diclofenac—Tachycardia—Epirubicin—bone cancer	7.01e-05	0.000543	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Methotrexate—bone cancer	6.99e-05	0.000542	CcSEcCtD
Diclofenac—Skin disorder—Epirubicin—bone cancer	6.97e-05	0.00054	CcSEcCtD
Diclofenac—Hyperhidrosis—Epirubicin—bone cancer	6.94e-05	0.000538	CcSEcCtD
Diclofenac—Insomnia—Methotrexate—bone cancer	6.94e-05	0.000538	CcSEcCtD
Diclofenac—Arthralgia—Doxorubicin—bone cancer	6.93e-05	0.000537	CcSEcCtD
Diclofenac—Chest pain—Doxorubicin—bone cancer	6.93e-05	0.000537	CcSEcCtD
Diclofenac—Myalgia—Doxorubicin—bone cancer	6.93e-05	0.000537	CcSEcCtD
Diclofenac—Anxiety—Doxorubicin—bone cancer	6.9e-05	0.000535	CcSEcCtD
Diclofenac—Paraesthesia—Methotrexate—bone cancer	6.89e-05	0.000534	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	6.88e-05	0.000533	CcSEcCtD
Diclofenac—Discomfort—Doxorubicin—bone cancer	6.84e-05	0.000531	CcSEcCtD
Diclofenac—Anorexia—Epirubicin—bone cancer	6.84e-05	0.00053	CcSEcCtD
Diclofenac—Dyspnoea—Methotrexate—bone cancer	6.84e-05	0.00053	CcSEcCtD
Diclofenac—Somnolence—Methotrexate—bone cancer	6.82e-05	0.000529	CcSEcCtD
Diclofenac—Dry mouth—Doxorubicin—bone cancer	6.78e-05	0.000525	CcSEcCtD
Diclofenac—Dyspepsia—Methotrexate—bone cancer	6.75e-05	0.000523	CcSEcCtD
Diclofenac—Hypotension—Epirubicin—bone cancer	6.71e-05	0.00052	CcSEcCtD
Diclofenac—Confusional state—Doxorubicin—bone cancer	6.7e-05	0.000519	CcSEcCtD
Diclofenac—Decreased appetite—Methotrexate—bone cancer	6.67e-05	0.000517	CcSEcCtD
Diclofenac—Anaphylactic shock—Doxorubicin—bone cancer	6.64e-05	0.000515	CcSEcCtD
Diclofenac—Oedema—Doxorubicin—bone cancer	6.64e-05	0.000515	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Methotrexate—bone cancer	6.62e-05	0.000513	CcSEcCtD
Diclofenac—Fatigue—Methotrexate—bone cancer	6.61e-05	0.000513	CcSEcCtD
Diclofenac—Infection—Doxorubicin—bone cancer	6.6e-05	0.000511	CcSEcCtD
Diclofenac—Pain—Methotrexate—bone cancer	6.56e-05	0.000508	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Epirubicin—bone cancer	6.54e-05	0.000507	CcSEcCtD
Diclofenac—Shock—Doxorubicin—bone cancer	6.53e-05	0.000506	CcSEcCtD
Diclofenac—Nervous system disorder—Doxorubicin—bone cancer	6.51e-05	0.000505	CcSEcCtD
Diclofenac—Thrombocytopenia—Doxorubicin—bone cancer	6.5e-05	0.000504	CcSEcCtD
Diclofenac—Insomnia—Epirubicin—bone cancer	6.49e-05	0.000503	CcSEcCtD
Diclofenac—Tachycardia—Doxorubicin—bone cancer	6.48e-05	0.000502	CcSEcCtD
Diclofenac—Skin disorder—Doxorubicin—bone cancer	6.45e-05	0.0005	CcSEcCtD
Diclofenac—Paraesthesia—Epirubicin—bone cancer	6.45e-05	0.0005	CcSEcCtD
Diclofenac—Hyperhidrosis—Doxorubicin—bone cancer	6.42e-05	0.000498	CcSEcCtD
Diclofenac—TTR—connective tissue—bone cancer	6.41e-05	0.034	CbGeAlD
Diclofenac—Dyspnoea—Epirubicin—bone cancer	6.4e-05	0.000496	CcSEcCtD
Diclofenac—Somnolence—Epirubicin—bone cancer	6.38e-05	0.000495	CcSEcCtD
Diclofenac—Anorexia—Doxorubicin—bone cancer	6.33e-05	0.000491	CcSEcCtD
Diclofenac—Feeling abnormal—Methotrexate—bone cancer	6.32e-05	0.00049	CcSEcCtD
Diclofenac—Dyspepsia—Epirubicin—bone cancer	6.32e-05	0.00049	CcSEcCtD
Diclofenac—Gastrointestinal pain—Methotrexate—bone cancer	6.27e-05	0.000486	CcSEcCtD
Diclofenac—Decreased appetite—Epirubicin—bone cancer	6.24e-05	0.000484	CcSEcCtD
Diclofenac—Hypotension—Doxorubicin—bone cancer	6.21e-05	0.000481	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Epirubicin—bone cancer	6.2e-05	0.00048	CcSEcCtD
Diclofenac—Fatigue—Epirubicin—bone cancer	6.19e-05	0.00048	CcSEcCtD
Diclofenac—Pain—Epirubicin—bone cancer	6.14e-05	0.000476	CcSEcCtD
Diclofenac—Constipation—Epirubicin—bone cancer	6.14e-05	0.000476	CcSEcCtD
Diclofenac—Urticaria—Methotrexate—bone cancer	6.09e-05	0.000472	CcSEcCtD
Diclofenac—Abdominal pain—Methotrexate—bone cancer	6.06e-05	0.00047	CcSEcCtD
Diclofenac—Body temperature increased—Methotrexate—bone cancer	6.06e-05	0.00047	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Doxorubicin—bone cancer	6.05e-05	0.000469	CcSEcCtD
Diclofenac—Insomnia—Doxorubicin—bone cancer	6.01e-05	0.000466	CcSEcCtD
Diclofenac—Paraesthesia—Doxorubicin—bone cancer	5.96e-05	0.000462	CcSEcCtD
Diclofenac—Dyspnoea—Doxorubicin—bone cancer	5.92e-05	0.000459	CcSEcCtD
Diclofenac—Feeling abnormal—Epirubicin—bone cancer	5.91e-05	0.000458	CcSEcCtD
Diclofenac—Somnolence—Doxorubicin—bone cancer	5.9e-05	0.000458	CcSEcCtD
Diclofenac—Gastrointestinal pain—Epirubicin—bone cancer	5.87e-05	0.000455	CcSEcCtD
Diclofenac—Dyspepsia—Doxorubicin—bone cancer	5.85e-05	0.000453	CcSEcCtD
Diclofenac—PLA2G2A—tendon—bone cancer	5.84e-05	0.0309	CbGeAlD
Diclofenac—ALOX5—connective tissue—bone cancer	5.81e-05	0.0308	CbGeAlD
Diclofenac—Decreased appetite—Doxorubicin—bone cancer	5.77e-05	0.000448	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Doxorubicin—bone cancer	5.73e-05	0.000444	CcSEcCtD
Diclofenac—Fatigue—Doxorubicin—bone cancer	5.73e-05	0.000444	CcSEcCtD
Diclofenac—Urticaria—Epirubicin—bone cancer	5.7e-05	0.000442	CcSEcCtD
Diclofenac—Constipation—Doxorubicin—bone cancer	5.68e-05	0.00044	CcSEcCtD
Diclofenac—Pain—Doxorubicin—bone cancer	5.68e-05	0.00044	CcSEcCtD
Diclofenac—Body temperature increased—Epirubicin—bone cancer	5.67e-05	0.00044	CcSEcCtD
Diclofenac—Abdominal pain—Epirubicin—bone cancer	5.67e-05	0.00044	CcSEcCtD
Diclofenac—Hypersensitivity—Methotrexate—bone cancer	5.65e-05	0.000438	CcSEcCtD
Diclofenac—CXCL8—bone marrow—bone cancer	5.6e-05	0.0296	CbGeAlD
Diclofenac—CXCL8—spinal cord—bone cancer	5.57e-05	0.0295	CbGeAlD
Diclofenac—Asthenia—Methotrexate—bone cancer	5.5e-05	0.000427	CcSEcCtD
Diclofenac—Feeling abnormal—Doxorubicin—bone cancer	5.47e-05	0.000424	CcSEcCtD
Diclofenac—Gastrointestinal pain—Doxorubicin—bone cancer	5.43e-05	0.000421	CcSEcCtD
Diclofenac—Pruritus—Methotrexate—bone cancer	5.43e-05	0.000421	CcSEcCtD
Diclofenac—Hypersensitivity—Epirubicin—bone cancer	5.29e-05	0.00041	CcSEcCtD
Diclofenac—Urticaria—Doxorubicin—bone cancer	5.28e-05	0.000409	CcSEcCtD
Diclofenac—Abdominal pain—Doxorubicin—bone cancer	5.25e-05	0.000407	CcSEcCtD
Diclofenac—Body temperature increased—Doxorubicin—bone cancer	5.25e-05	0.000407	CcSEcCtD
Diclofenac—Diarrhoea—Methotrexate—bone cancer	5.25e-05	0.000407	CcSEcCtD
Diclofenac—Asthenia—Epirubicin—bone cancer	5.15e-05	0.000399	CcSEcCtD
Diclofenac—Pruritus—Epirubicin—bone cancer	5.08e-05	0.000394	CcSEcCtD
Diclofenac—Dizziness—Methotrexate—bone cancer	5.07e-05	0.000393	CcSEcCtD
Diclofenac—Diarrhoea—Epirubicin—bone cancer	4.91e-05	0.000381	CcSEcCtD
Diclofenac—Hypersensitivity—Doxorubicin—bone cancer	4.89e-05	0.000379	CcSEcCtD
Diclofenac—Vomiting—Methotrexate—bone cancer	4.88e-05	0.000378	CcSEcCtD
Diclofenac—Rash—Methotrexate—bone cancer	4.84e-05	0.000375	CcSEcCtD
Diclofenac—Dermatitis—Methotrexate—bone cancer	4.83e-05	0.000375	CcSEcCtD
Diclofenac—Headache—Methotrexate—bone cancer	4.8e-05	0.000372	CcSEcCtD
Diclofenac—Asthenia—Doxorubicin—bone cancer	4.76e-05	0.000369	CcSEcCtD
Diclofenac—SLCO1C1—spinal cord—bone cancer	4.76e-05	0.0252	CbGeAlD
Diclofenac—Dizziness—Epirubicin—bone cancer	4.75e-05	0.000368	CcSEcCtD
Diclofenac—Pruritus—Doxorubicin—bone cancer	4.7e-05	0.000364	CcSEcCtD
Diclofenac—Vomiting—Epirubicin—bone cancer	4.56e-05	0.000354	CcSEcCtD
Diclofenac—Nausea—Methotrexate—bone cancer	4.56e-05	0.000353	CcSEcCtD
Diclofenac—Diarrhoea—Doxorubicin—bone cancer	4.54e-05	0.000352	CcSEcCtD
Diclofenac—SCN4A—tendon—bone cancer	4.53e-05	0.024	CbGeAlD
Diclofenac—Rash—Epirubicin—bone cancer	4.53e-05	0.000351	CcSEcCtD
Diclofenac—Dermatitis—Epirubicin—bone cancer	4.52e-05	0.00035	CcSEcCtD
Diclofenac—Headache—Epirubicin—bone cancer	4.5e-05	0.000349	CcSEcCtD
Diclofenac—Dizziness—Doxorubicin—bone cancer	4.39e-05	0.00034	CcSEcCtD
Diclofenac—TTR—bone marrow—bone cancer	4.27e-05	0.0226	CbGeAlD
Diclofenac—Nausea—Epirubicin—bone cancer	4.26e-05	0.00033	CcSEcCtD
Diclofenac—TTR—spinal cord—bone cancer	4.25e-05	0.0225	CbGeAlD
Diclofenac—Vomiting—Doxorubicin—bone cancer	4.22e-05	0.000327	CcSEcCtD
Diclofenac—Rash—Doxorubicin—bone cancer	4.19e-05	0.000325	CcSEcCtD
Diclofenac—Dermatitis—Doxorubicin—bone cancer	4.18e-05	0.000324	CcSEcCtD
Diclofenac—Headache—Doxorubicin—bone cancer	4.16e-05	0.000322	CcSEcCtD
Diclofenac—Nausea—Doxorubicin—bone cancer	3.94e-05	0.000306	CcSEcCtD
Diclofenac—ALOX5—bone marrow—bone cancer	3.87e-05	0.0205	CbGeAlD
Diclofenac—CXCL8—Cellular responses to stress—JUN—bone cancer	3.76e-05	0.000452	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—GRM4—bone cancer	3.74e-05	0.00045	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—RGS1—bone cancer	3.74e-05	0.00045	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	3.73e-05	0.000449	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—ENO2—bone cancer	3.67e-05	0.000441	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—NT5C3A—bone cancer	3.63e-05	0.000437	CbGpPWpGaD
Diclofenac—CYP2C19—Biological oxidations—GSTP1—bone cancer	3.61e-05	0.000434	CbGpPWpGaD
Diclofenac—ALB—Transmembrane transport of small molecules—TUBB4B—bone cancer	3.6e-05	0.000433	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—TGFBR2—bone cancer	3.59e-05	0.000432	CbGpPWpGaD
Diclofenac—ALB—Selenium Micronutrient Network—PTGS2—bone cancer	3.56e-05	0.000428	CbGpPWpGaD
Diclofenac—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	3.56e-05	0.000428	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—GNA11—bone cancer	3.54e-05	0.000426	CbGpPWpGaD
Diclofenac—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	3.54e-05	0.000426	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—IL3—bone cancer	3.53e-05	0.000425	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—NDUFA12—bone cancer	3.48e-05	0.000419	CbGpPWpGaD
Diclofenac—SCN4A—Axon guidance—EGFR—bone cancer	3.48e-05	0.000418	CbGpPWpGaD
Diclofenac—TTR—Disease—TGFBR2—bone cancer	3.45e-05	0.000415	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—SMO—bone cancer	3.41e-05	0.00041	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—DHFR—bone cancer	3.4e-05	0.00041	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—IGF1R—bone cancer	3.38e-05	0.000407	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—GSTP1—bone cancer	3.36e-05	0.000404	CbGpPWpGaD
Diclofenac—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	3.35e-05	0.000403	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—NDUFA12—bone cancer	3.34e-05	0.000402	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	3.31e-05	0.000398	CbGpPWpGaD
Diclofenac—CYP2C9—Biological oxidations—GSTP1—bone cancer	3.29e-05	0.000396	CbGpPWpGaD
Diclofenac—CYP1A2—Biological oxidations—CYP3A4—bone cancer	3.28e-05	0.000395	CbGpPWpGaD
Diclofenac—CXCL8—Cellular Senescence—TP53—bone cancer	3.28e-05	0.000395	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—NDUFA12—bone cancer	3.28e-05	0.000394	CbGpPWpGaD
Diclofenac—KCNQ3—Developmental Biology—EGFR—bone cancer	3.27e-05	0.000394	CbGpPWpGaD
Diclofenac—KCNQ2—Developmental Biology—EGFR—bone cancer	3.27e-05	0.000394	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—GRM1—bone cancer	3.24e-05	0.00039	CbGpPWpGaD
Diclofenac—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	3.24e-05	0.00039	CbGpPWpGaD
Diclofenac—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	3.24e-05	0.00039	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—IL3—bone cancer	3.21e-05	0.000386	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—GNA11—bone cancer	3.18e-05	0.000383	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	3.16e-05	0.000381	CbGpPWpGaD
Diclofenac—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	3.15e-05	0.00038	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—GNA11—bone cancer	3.12e-05	0.000375	CbGpPWpGaD
Diclofenac—ALB—Transmembrane transport of small molecules—TUBB2A—bone cancer	3.11e-05	0.000374	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—NDUFA12—bone cancer	3.09e-05	0.000372	CbGpPWpGaD
Diclofenac—SCN4A—Developmental Biology—MMP9—bone cancer	3.07e-05	0.000369	CbGpPWpGaD
Diclofenac—PTGS2—Spinal Cord Injury—MMP9—bone cancer	3.05e-05	0.000367	CbGpPWpGaD
Diclofenac—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	2.96e-05	0.000357	CbGpPWpGaD
Diclofenac—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	2.96e-05	0.000357	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—ATF1—bone cancer	2.9e-05	0.000349	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—CYP3A4—bone cancer	2.88e-05	0.000347	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—NT5C3A—bone cancer	2.88e-05	0.000347	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—PLAU—bone cancer	2.87e-05	0.000346	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.87e-05	0.000345	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—NDUFA12—bone cancer	2.83e-05	0.000341	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—IL3—bone cancer	2.83e-05	0.00034	CbGpPWpGaD
Diclofenac—ALB—Metabolism—NDUFA12—bone cancer	2.81e-05	0.000339	CbGpPWpGaD
Diclofenac—CYP1A2—Biological oxidations—GSTP1—bone cancer	2.81e-05	0.000338	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—NT5C3A—bone cancer	2.77e-05	0.000333	CbGpPWpGaD
Diclofenac—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	2.77e-05	0.000333	CbGpPWpGaD
Diclofenac—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	2.72e-05	0.000328	CbGpPWpGaD
Diclofenac—ABCC4—tendon—bone cancer	2.72e-05	0.0144	CbGeAlD
Diclofenac—CYP2E1—Metabolism—NT5C3A—bone cancer	2.71e-05	0.000327	CbGpPWpGaD
Diclofenac—ALB—Folate Metabolism—TP53—bone cancer	2.66e-05	0.000321	CbGpPWpGaD
Diclofenac—ABCC4—bone marrow—bone cancer	2.64e-05	0.014	CbGeAlD
Diclofenac—CYP1A1—Metabolism—NT5C3A—bone cancer	2.56e-05	0.000308	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—NDUFA12—bone cancer	2.53e-05	0.000304	CbGpPWpGaD
Diclofenac—SCN4A—Developmental Biology—EGFR—bone cancer	2.48e-05	0.000298	CbGpPWpGaD
Diclofenac—CXCL8—Cellular responses to stress—TP53—bone cancer	2.48e-05	0.000298	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—ENO2—bone cancer	2.47e-05	0.000297	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—NDUFA12—bone cancer	2.47e-05	0.000297	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—GSTP1—bone cancer	2.47e-05	0.000297	CbGpPWpGaD
Diclofenac—PTGS2—Spinal Cord Injury—EGFR—bone cancer	2.46e-05	0.000297	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	2.45e-05	0.000295	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—KIT—bone cancer	2.45e-05	0.000295	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—TGFBR2—bone cancer	2.42e-05	0.000291	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—ENO2—bone cancer	2.4e-05	0.000289	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—SPARC—bone cancer	2.39e-05	0.000287	CbGpPWpGaD
Diclofenac—TTR—Disease—KIT—bone cancer	2.35e-05	0.000283	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	2.35e-05	0.000282	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—NT5C3A—bone cancer	2.35e-05	0.000282	CbGpPWpGaD
Diclofenac—ALB—Metabolism—NT5C3A—bone cancer	2.33e-05	0.000281	CbGpPWpGaD
Diclofenac—PTGS1—connective tissue—bone cancer	2.33e-05	0.0124	CbGeAlD
Diclofenac—ABCC1—tendon—bone cancer	2.32e-05	0.0123	CbGeAlD
Diclofenac—CYP2C9—Metabolism—NDUFA12—bone cancer	2.3e-05	0.000277	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—BRAF—bone cancer	2.3e-05	0.000277	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—DHFR—bone cancer	2.29e-05	0.000276	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—SMO—bone cancer	2.29e-05	0.000275	CbGpPWpGaD
Diclofenac—CXCL8—Metabolism of proteins—MMP2—bone cancer	2.27e-05	0.000274	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—IGF1R—bone cancer	2.27e-05	0.000274	CbGpPWpGaD
Diclofenac—ABCC1—Disease—ENO2—bone cancer	2.25e-05	0.00027	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—EGFR—bone cancer	2.23e-05	0.000269	CbGpPWpGaD
Diclofenac—PTGS2—connective tissue—bone cancer	2.23e-05	0.0118	CbGeAlD
Diclofenac—UGT2B7—Metabolism—DHFR—bone cancer	2.23e-05	0.000268	CbGpPWpGaD
Diclofenac—TTR—Disease—BRAF—bone cancer	2.21e-05	0.000266	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—GNA11—bone cancer	2.18e-05	0.000263	CbGpPWpGaD
Diclofenac—CYP3A4—Biological oxidations—GSTP1—bone cancer	2.17e-05	0.000261	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—GNA11—bone cancer	2.14e-05	0.000258	CbGpPWpGaD
Diclofenac—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	2.14e-05	0.000257	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	2.13e-05	0.000257	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—NT5C3A—bone cancer	2.09e-05	0.000252	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—GNA11—bone cancer	2.09e-05	0.000252	CbGpPWpGaD
Diclofenac—ABCC1—Disease—DHFR—bone cancer	2.08e-05	0.000251	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—GNA11—bone cancer	2.08e-05	0.000251	CbGpPWpGaD
Diclofenac—PTGS2—Spinal Cord Injury—TP53—bone cancer	2.07e-05	0.000249	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—NT5C3A—bone cancer	2.04e-05	0.000246	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—IL3—bone cancer	1.98e-05	0.000238	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—NDUFA12—bone cancer	1.97e-05	0.000237	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—ENO2—bone cancer	1.95e-05	0.000235	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—ATF1—bone cancer	1.94e-05	0.000234	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—CYP3A4—bone cancer	1.94e-05	0.000234	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—MDM2—bone cancer	1.93e-05	0.000232	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—NT5C3A—bone cancer	1.91e-05	0.00023	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—IL3—bone cancer	1.89e-05	0.000228	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—CYP3A4—bone cancer	1.89e-05	0.000227	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—ENO2—bone cancer	1.88e-05	0.000226	CbGpPWpGaD
Diclofenac—TTR—Disease—MDM2—bone cancer	1.85e-05	0.000223	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—DHFR—bone cancer	1.81e-05	0.000218	CbGpPWpGaD
Diclofenac—TTR—Disease—PTGS2—bone cancer	1.79e-05	0.000215	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—DHFR—bone cancer	1.75e-05	0.00021	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—PTGS2—bone cancer	1.74e-05	0.000209	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	1.74e-05	0.000209	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—GNA11—bone cancer	1.69e-05	0.000204	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—JUN—bone cancer	1.68e-05	0.000202	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	1.68e-05	0.000202	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	1.68e-05	0.000202	CbGpPWpGaD
Diclofenac—CYP2E1—tendon—bone cancer	1.66e-05	0.00881	CbGeAlD
Diclofenac—CYP2C18—Metabolism—GSTP1—bone cancer	1.66e-05	0.0002	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—KIT—bone cancer	1.65e-05	0.000198	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—MMP9—bone cancer	1.63e-05	0.000196	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—GNA11—bone cancer	1.63e-05	0.000196	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—NT5C3A—bone cancer	1.63e-05	0.000196	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TGFBR2—bone cancer	1.62e-05	0.000195	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—GSTP1—bone cancer	1.61e-05	0.000194	CbGpPWpGaD
Diclofenac—CYP2E1—spinal cord—bone cancer	1.61e-05	0.0085	CbGeAlD
Diclofenac—PTGS1—tendon—bone cancer	1.6e-05	0.00849	CbGeAlD
Diclofenac—PTGS1—Metabolism—ENO2—bone cancer	1.59e-05	0.000191	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—BRAF—bone cancer	1.55e-05	0.000186	CbGpPWpGaD
Diclofenac—PTGS1—spinal cord—bone cancer	1.55e-05	0.00819	CbGeAlD
Diclofenac—UGT1A1—Metabolism—CYP3A4—bone cancer	1.53e-05	0.000185	CbGpPWpGaD
Diclofenac—PTGS2—tendon—bone cancer	1.53e-05	0.00812	CbGeAlD
Diclofenac—CXCL8—Signaling Pathways—IGF1R—bone cancer	1.52e-05	0.000183	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—NDUFA12—bone cancer	1.52e-05	0.000183	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	1.51e-05	0.000182	CbGpPWpGaD
Diclofenac—ABCC1—Disease—TGFBR2—bone cancer	1.51e-05	0.000182	CbGpPWpGaD
Diclofenac—PTGS2—Disease—ENO2—bone cancer	1.51e-05	0.000181	CbGpPWpGaD
Diclofenac—PTGS2—bone marrow—bone cancer	1.48e-05	0.00786	CbGeAlD
Diclofenac—ABCC1—Metabolism—CYP3A4—bone cancer	1.48e-05	0.000178	CbGpPWpGaD
Diclofenac—PTGS2—spinal cord—bone cancer	1.48e-05	0.00783	CbGeAlD
Diclofenac—PTGS1—Metabolism—DHFR—bone cancer	1.48e-05	0.000178	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.47e-05	0.000177	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.41e-05	0.000169	CbGpPWpGaD
Diclofenac—PTGS2—Disease—DHFR—bone cancer	1.4e-05	0.000168	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—GNA11—bone cancer	1.38e-05	0.000166	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—EGFR—bone cancer	1.32e-05	0.000159	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—GSTP1—bone cancer	1.31e-05	0.000158	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—PLAU—bone cancer	1.3e-05	0.000156	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—MDM2—bone cancer	1.3e-05	0.000156	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—PTGS2—bone cancer	1.28e-05	0.000154	CbGpPWpGaD
Diclofenac—TTR—Disease—EGFR—bone cancer	1.27e-05	0.000152	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—GSTP1—bone cancer	1.27e-05	0.000152	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—ENO2—bone cancer	1.26e-05	0.000152	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—NT5C3A—bone cancer	1.26e-05	0.000152	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—CYP3A4—bone cancer	1.25e-05	0.00015	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.24e-05	0.00015	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—ENO2—bone cancer	1.21e-05	0.000146	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—ENO2—bone cancer	1.19e-05	0.000143	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	1.19e-05	0.000143	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—DHFR—bone cancer	1.17e-05	0.000141	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—TP53—bone cancer	1.15e-05	0.000139	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—JUN—bone cancer	1.13e-05	0.000136	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—DHFR—bone cancer	1.13e-05	0.000136	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—ENO2—bone cancer	1.12e-05	0.000135	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—TP53—bone cancer	1.11e-05	0.000133	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—KIT—bone cancer	1.11e-05	0.000133	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—DHFR—bone cancer	1.1e-05	0.000133	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—MMP9—bone cancer	1.1e-05	0.000132	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—GNA11—bone cancer	1.09e-05	0.000132	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—GSTP1—bone cancer	1.07e-05	0.000129	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—GNA11—bone cancer	1.05e-05	0.000127	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—DHFR—bone cancer	1.04e-05	0.000125	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—BRAF—bone cancer	1.04e-05	0.000125	CbGpPWpGaD
Diclofenac—ABCC1—Disease—KIT—bone cancer	1.03e-05	0.000124	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—GNA11—bone cancer	1.03e-05	0.000124	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—ENO2—bone cancer	1.03e-05	0.000124	CbGpPWpGaD
Diclofenac—ALB—Metabolism—ENO2—bone cancer	1.02e-05	0.000123	CbGpPWpGaD
Diclofenac—PTGS2—Disease—TGFBR2—bone cancer	1.01e-05	0.000122	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—EGFR—bone cancer	1.01e-05	0.000121	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	9.98e-06	0.00012	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—CYP3A4—bone cancer	9.93e-06	0.000119	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—GNA11—bone cancer	9.72e-06	0.000117	CbGpPWpGaD
Diclofenac—ABCC1—Disease—BRAF—bone cancer	9.69e-06	0.000117	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—CYP3A4—bone cancer	9.54e-06	0.000115	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—DHFR—bone cancer	9.53e-06	0.000115	CbGpPWpGaD
Diclofenac—ALB—Metabolism—DHFR—bone cancer	9.48e-06	0.000114	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—CYP3A4—bone cancer	9.34e-06	0.000112	CbGpPWpGaD
Diclofenac—ABCB1—bone marrow—bone cancer	9.18e-06	0.00486	CbGeAlD
Diclofenac—CYP2C19—Metabolism—ENO2—bone cancer	9.17e-06	0.00011	CbGpPWpGaD
Diclofenac—ABCB1—spinal cord—bone cancer	9.14e-06	0.00484	CbGeAlD
Diclofenac—ABCB1—Metabolism—ENO2—bone cancer	8.95e-06	0.000108	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—GNA11—bone cancer	8.91e-06	0.000107	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—EGFR—bone cancer	8.87e-06	0.000107	CbGpPWpGaD
Diclofenac—ALB—Metabolism—GNA11—bone cancer	8.86e-06	0.000107	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—CYP3A4—bone cancer	8.81e-06	0.000106	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	8.77e-06	0.000105	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MDM2—bone cancer	8.71e-06	0.000105	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—PTGS2—bone cancer	8.6e-06	0.000103	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—DHFR—bone cancer	8.51e-06	0.000102	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—GSTP1—bone cancer	8.49e-06	0.000102	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—PTGS2—bone cancer	8.36e-06	0.000101	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—ENO2—bone cancer	8.36e-06	0.000101	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—DHFR—bone cancer	8.3e-06	9.99e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—GSTP1—bone cancer	8.16e-06	9.82e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—MDM2—bone cancer	8.12e-06	9.77e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—CYP3A4—bone cancer	8.08e-06	9.72e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	8.04e-06	9.67e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—CYP3A4—bone cancer	8.03e-06	9.66e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—GSTP1—bone cancer	7.99e-06	9.62e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	7.99e-06	9.62e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—GNA11—bone cancer	7.95e-06	9.57e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—PTGS2—bone cancer	7.83e-06	9.42e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—GNA11—bone cancer	7.76e-06	9.34e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—DHFR—bone cancer	7.76e-06	9.34e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—JUN—bone cancer	7.57e-06	9.11e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—GSTP1—bone cancer	7.53e-06	9.07e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—TP53—bone cancer	7.45e-06	8.97e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MMP9—bone cancer	7.36e-06	8.86e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GNA11—bone cancer	7.25e-06	8.73e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CYP3A4—bone cancer	7.21e-06	8.68e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	7.17e-06	8.63e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—ENO2—bone cancer	7.15e-06	8.6e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CYP3A4—bone cancer	7.04e-06	8.47e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—KIT—bone cancer	6.92e-06	8.32e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—GSTP1—bone cancer	6.91e-06	8.31e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—GSTP1—bone cancer	6.87e-06	8.27e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PTGS2—bone cancer	6.8e-06	8.18e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—DHFR—bone cancer	6.63e-06	7.98e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CYP3A4—bone cancer	6.57e-06	7.91e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PTGS2—bone cancer	6.55e-06	7.89e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	6.54e-06	7.87e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—BRAF—bone cancer	6.5e-06	7.82e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GNA11—bone cancer	6.2e-06	7.46e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—GSTP1—bone cancer	6.17e-06	7.42e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—GSTP1—bone cancer	6.02e-06	7.24e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—EGFR—bone cancer	5.95e-06	7.16e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GSTP1—bone cancer	5.62e-06	6.77e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CYP3A4—bone cancer	5.62e-06	6.76e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	5.59e-06	6.73e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—EGFR—bone cancer	5.55e-06	6.68e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PTGS2—bone cancer	5.54e-06	6.67e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ENO2—bone cancer	5.52e-06	6.64e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MDM2—bone cancer	5.45e-06	6.56e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—TP53—bone cancer	5.22e-06	6.29e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—DHFR—bone cancer	5.12e-06	6.16e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TP53—bone cancer	5e-06	6.01e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GSTP1—bone cancer	4.8e-06	5.78e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GNA11—bone cancer	4.78e-06	5.75e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PTGS2—bone cancer	4.23e-06	5.09e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PTGS2—bone cancer	4.14e-06	4.98e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PTGS2—bone cancer	3.9e-06	4.7e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—EGFR—bone cancer	3.72e-06	4.48e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GSTP1—bone cancer	3.71e-06	4.46e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PTGS2—bone cancer	3.58e-06	4.31e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PTGS2—bone cancer	3.56e-06	4.28e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PTGS2—bone cancer	3.19e-06	3.84e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PTGS2—bone cancer	3.12e-06	3.75e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PTGS2—bone cancer	2.91e-06	3.51e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PTGS2—bone cancer	2.49e-06	3e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PTGS2—bone cancer	1.92e-06	2.31e-05	CbGpPWpGaD
